Stock Track | Consun Pharmaceutical Soars 9% on Robust H1 Results, Dividend Announcement

Stock Track08-21

Shares of Consun Pharmaceutical Group Limited (HKG:1681) surged as much as 9.09% in intraday trading on August 21, 2024, following the company's release of its interim financial results for the first half of the year.

According to a filing with the Hong Kong stock exchange, Consun Pharmaceutical reported a 15% increase in profit attributable to owners, reaching 399.8 million yuan for the six months ended June 30, 2024. The company's revenue for the same period grew by 13% year-over-year to 1.27 billion yuan.

The strong financial performance prompted the pharmaceutical firm to propose an interim dividend of HK$0.003 per share. Investors reacted positively to the news, driving Consun Pharmaceutical's share price up by 7% in recent trading, as mentioned in the company's filing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment